Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Journal of Clinical Medicine
|
October 29, 2025
Pharmacokinetics and Monitoring of Methotrexate in Adults with Acute Lymphoblastic Leukaemia: A 10-Year Follow-Up at an Italian Centre
Pasquale Fabio Calabrò, Letizia Biso, Marianna Lastella, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer
Evan Y Yu, George Wilding, Edwin Posadas, et al.
Cancers
|
September 17, 2020
Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
Ilaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo, et al.
Clinical Drug Investigation
|
June 6, 2026
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy
Andrea Marcellusi, Fabio Calabrò, Anna Maria Di Giacomo, et al.
Technology in Cancer Research & Treatment
|
February 24, 2025
Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy
Ria Nagpal, Marina Campione, Sara Elena Rebuzzi, et al.
Journal of Clinical Medicine
|
September 28, 2024
Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab
Rocco Simone Flammia, Gabriele Tuderti, Eugenio Bologna, et al.
Clinical Genitourinary Cancer
|
October 15, 2024
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Annalisa Guida, Alessio Gili, Claudia Mosillo, et al.
European Urology Open Science
|
July 11, 2026
The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors
Roberto Iacovelli, Chiara Ciccarese, Daniela Arduini, et al.
Prostate Cancer and Prostatic Diseases
|
December 2, 2022
The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort
Mariaconsiglia Ferriero, Francesco Prata, Riccardo Mastroianni, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Journal of Clinical Medicine
|
October 29, 2025
Pharmacokinetics and Monitoring of Methotrexate in Adults with Acute Lymphoblastic Leukaemia: A 10-Year Follow-Up at an Italian Centre
Pasquale Fabio Calabrò, Letizia Biso, Marianna Lastella, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer
Evan Y Yu, George Wilding, Edwin Posadas, et al.
Cancers
|
September 17, 2020
Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
Ilaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo, et al.
Clinical Drug Investigation
|
June 6, 2026
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy
Andrea Marcellusi, Fabio Calabrò, Anna Maria Di Giacomo, et al.
Technology in Cancer Research & Treatment
|
February 24, 2025
Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy
Ria Nagpal, Marina Campione, Sara Elena Rebuzzi, et al.
Journal of Clinical Medicine
|
September 28, 2024
Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab
Rocco Simone Flammia, Gabriele Tuderti, Eugenio Bologna, et al.
Clinical Genitourinary Cancer
|
October 15, 2024
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Annalisa Guida, Alessio Gili, Claudia Mosillo, et al.
European Urology Open Science
|
July 11, 2026
The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors
Roberto Iacovelli, Chiara Ciccarese, Daniela Arduini, et al.
Prostate Cancer and Prostatic Diseases
|
December 2, 2022
The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort
Mariaconsiglia Ferriero, Francesco Prata, Riccardo Mastroianni, et al.
Page
of 8